Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Rapid progression of prostate cancer in men with a BRCA2 mutation.

Narod SA, Neuhausen S, Vichodez G, Armel S, Lynch HT, Ghadirian P, Cummings S, Olopade O, Stoppa-Lyonnet D, Couch F, Wagner T, Warner E, Foulkes WD, Saal H, Weitzel J, Tulman A, Poll A, Nam R, Sun P; Hereditary Breast Cancer Study Group, Danquah J, Domchek S, Tung N, Ainsworth P, Horsman D, Kim-Sing C, Maugard C, Eisen A, Daly M, McKinnon W, Wood M, Isaacs C, Gilchrist D, Karlan B, Nedelcu R, Meschino W, Garber J, Pasini B, Manoukian S, Bellati C.

Br J Cancer. 2008 Jul 22;99(2):371-4. doi: 10.1038/sj.bjc.6604453. Epub 2008 Jun 24.

2.

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

Willems AJ, Dawson SJ, Samaratunga H, De Luca A, Antill YC, Hopper JL, Thorne HJ; kConFab Investigators.

Clin Cancer Res. 2008 May 15;14(10):2953-61. doi: 10.1158/1078-0432.CCR-07-5237. Epub 2008 Apr 29.

3.

Re: Prostate cancer progression and survival in BRCA2 mutation carriers.

Boormans JL, Schröder FH.

Eur Urol. 2007 Nov;52(5):1529. No abstract available.

PMID:
17985426
4.

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.

Tommiska J, Bartkova J, Heinonen M, Hautala L, Kilpivaara O, Eerola H, Aittomäki K, Hofstetter B, Lukas J, von Smitten K, Blomqvist C, Ristimäki A, Heikkilä P, Bartek J, Nevanlinna H.

Oncogene. 2008 Apr 10;27(17):2501-6. Epub 2007 Nov 5.

PMID:
17982490
5.

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.

Agalliu I, Karlins E, Kwon EM, Iwasaki LM, Diamond A, Ostrander EA, Stanford JL.

Br J Cancer. 2007 Sep 17;97(6):826-31. Epub 2007 Aug 14.

6.

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.

J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.

PMID:
17565157
7.

A review of targeted screening for prostate cancer: introducing the IMPACT study.

Mitra AV, Bancroft EK, Eeles RA; IMPACT Steering Committee and Collaborators.

BJU Int. 2007 Jun;99(6):1350-5. Epub 2007 Apr 5. Review. No abstract available. Erratum in: BJU Int. 2007 Sep;100(3):718-9.

8.
9.

Unravelling the genetics of prostate cancer.

Edwards SM, Eeles RA.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):65-73. Review.

PMID:
15264274
10.

Prediction of progression: nomograms of clinical utility.

Kattan MW, Scardino PT.

Clin Prostate Cancer. 2002 Sep;1(2):90-6. Review.

PMID:
15046699
12.

An investigation of the familial aspects of carcinoma of the prostate.

WOOLF CM.

Cancer. 1960 Jul-Aug;13:739-44. No abstract available.

PMID:
13845929
13.

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BA, Gayther SA, Easton DF, Eeles RA; Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators; British Association of Urological Surgeons Section of Oncology.

Am J Hum Genet. 2003 Jan;72(1):1-12. Epub 2002 Dec 9.

14.

Cancer Incidence in BRCA1 mutation carriers.

Thompson D, Easton DF; Breast Cancer Linkage Consortium.

J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65.

PMID:
12237281
15.

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Thompson D, Easton D; Breast Cancer Linkage Consortium.

Am J Hum Genet. 2001 Feb;68(2):410-9. Epub 2001 Jan 19.

16.

BRCA2 mutation in a family with hereditary prostate cancer.

Grönberg H, Ahman AK, Emanuelsson M, Bergh A, Damber JE, Borg A.

Genes Chromosomes Cancer. 2001 Mar;30(3):299-301.

PMID:
11170288
17.

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium.

J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6.

PMID:
10433620
18.

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

Edwards SM, Dunsmuir WD, Gillett CE, Lakhani SR, Corbishley C, Young M, Kirby RS, Dearnaley DP, Dowe A, Ardern-Jones A, Kelly J, Spurr N, Barnes DM, Eeles RA.

Int J Cancer. 1998 Sep 25;78(1):1-7.

19.

BRCA2 mutation in Icelandic prostate cancer patients.

Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, Jonsson E.

J Mol Med (Berl). 1997 Oct;75(10):758-61.

PMID:
9383000
20.

Supplemental Content

Support Center